MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
Kouji Banno(Keio University), Daisuke Aoki(International University of Health and Welfare), Kyoko Tanaka(Keio University), Iori Kisu(Fujita Health University), Eiichiro Tominaga(Keio University), Megumi Yanokura(Keio University), Takashi Iwata(Keio University), Miho Iida(Keio University)
Cited by 143
Related Papers
Pathological Steps of Cancer-Related Lymphedema: Histological Changes in the Collecting Lymphatic Vessels after Lymphadenectomy
|PLoS ONE|2012|331
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|214
Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
|Cancer Science|2008|105
Registry of the International Society of Uterus Transplantation: First Report
|Transplantation|2022|100
Uterine autotransplantation in cynomolgus macaques: the first case of pregnancy and delivery
|Human Reproduction|2012|97